Evox Therapeutics wins funding from Duchenne UK to explore exosome-mediated delivery of dystrophin

November 14, 2018 Leave a comment 1,140 Views

Evox Therapeutics, a leading exosome therapeutics company, a leading exosome therapeutics company, today announces that it has secured £655,000 in funding from Duchenne UK. The grant will be invested to support exploration of the Company’s exosome-based therapeutic platform to deliver ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Duchenne UK

Evox Therapeutics wins funding from Duchenne UK to explore exosome-mediated delivery of dystrophin

Scientists explain regulation of extracellular vesicles by dephosphorylating Syntenin

Overcoming Chemoresistance via Extracellular Vesicle Inhibition

Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential

Study focuses on a different kind of liquid biopsy to detect cancer

Raman spectral signatures of serum-derived EVs may serve as liquid biopsy for diagnosis of CNS tumors

Extracellular vesicles isolated from milk can improve gut barrier dysfunction induced by malnutrition